Literature DB >> 8131850

Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells.

S Eguchi1, Y Hirata, H Kano, K Sato, Y Watanabe, T X Watanabe, K Nakajima, S Sakakibara, F Marumo.   

Abstract

The effects of synthetic rat adrenomedullin (rAM), a novel vasorelaxant peptide originally isolated from human pheochromocytoma, on receptor binding and cAMP generation were studied in cultured rat vascular smooth muscle cells (VSMC). A binding study using [125I]rAM revealed the presence of a single class of high-affinity (Kd 1.3 x 10(-8) M) binding sites for rAM in VSMC. The apparent Ki of rat calcitonin gene-related peptide (rCGRP) was 3 x 10(-7) M. Affinity labeling of VSMC membranes with [125I]rAM revealed two distinct labeled bands with apparent molecular weights of 120 and 70 kDa, both of which were abolished by excess unlabeled rAM or rCGRP, rAM stimulated cAMP formation with an approximate EC50 of 10(-8) M, the effect of which was additive with isoproterenol, but not with rCGRP. The rAM-induced cAMP response was unaffected by propranolol, indomethacin, or quinacrine, but inhibited by a CGRP receptor antagonist, human CGRP[8-37]. These data suggest that VSMC possesses specific AM receptors functionally coupled to adenylate cyclase with which CGRP interacts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8131850     DOI: 10.1016/0014-5793(94)80143-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Receptors mediating CGRP-induced relaxation in the rat isolated thoracic aorta and porcine isolated coronary artery differentiated by h(alpha) CGRP(8-37).

Authors:  F M Wisskirchen; D W Gray; I Marshall
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

2.  Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1.

Authors:  Shaolong Yang; Mian Zhou; Irshad H Chaudry; Ping Wang
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Pregnancy Increases Relaxation in Human Omental Arteries to the CGRP Family of Peptides.

Authors:  Yuanlin Dong; Ancizar Betancourt; Madhu Chauhan; Meena Balakrishnan; Fernando Lugo; Matthew L Anderson; Jimmy Espinoza; Karin Fox; Michael Belfort; Chandrasekhar Yallampalli
Journal:  Biol Reprod       Date:  2015-10-28       Impact factor: 4.285

Review 4.  Novel neurohumoral factors in congestive heart failure: adrenomedullin.

Authors:  J G Lainchbury
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

Review 5.  Adrenomedullin. Implications for hypertension research.

Authors:  K Kitamura; K Kangawa; H Matsuo; T Eto
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

6.  A rat skeletal muscle cell line (L6) expresses specific adrenomedullin binding sites but activates adenylate cyclase via calcitonin gene-related peptide receptors.

Authors:  H A Coppock; A A Owji; S R Bloom; D M Smith
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

7.  Adrenomedullin increases fluid extravasation from the splenic circulation of the rat.

Authors:  S Kaufman; P Andrew; R Sultanian; Y Deng
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

8.  Analysis of responses to human synthetic adrenomedullin and calcitonin gene-related peptides in the hindlimb vascular bed of the cat.

Authors:  H C Champion; D L Akers; J A Santiago; D G Lambert; D B McNamara; P J Kadowitz
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

Review 9.  Adrenomedullin and diabetes.

Authors:  Hoi Kin Wong; Fai Tang; Tsang Tommy Cheung; Bernard Man Yung Cheung
Journal:  World J Diabetes       Date:  2014-06-15

10.  Coexpression of adrenomedullin and its receptor component proteins in the reproductive system of the rat during gestation.

Authors:  Lei Li; Fai Tang; Wai-Sum O
Journal:  Reprod Biol Endocrinol       Date:  2010-10-29       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.